Inotuzumab-ozogamicin/BlinatumomabNo response: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1864卷 / 1期
关键词：
D O I：
10.1007/s40278-021-99125-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 195
相关论文
共 50 条
  • [21] Inotuzumab ozogamicinThrombocytopenia: case report
    Reactions Weekly, 2019, 1734 (1) : 283 - 283
  • [22] Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
    Zhao, Yaqi
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Chang, Ti-Cheng
    Ghate, Pankaj S.
    Qu, Chunxu
    Macaron, Walid
    Jain, Nitin
    Thakral, Beenu
    Phillips, Aaron H.
    Khoury, Joseph
    Garcia-Manero, Guillermo
    Zhang, Wenchao
    Fan, Yiping
    Yang, Hui
    Garris, Rebecca S.
    Nasr, Lewis F.
    Kriwacki, Richard W.
    Roberts, Kathryn G.
    Konopleva, Marina
    Jabbour, Elias J.
    Mullighan, Charles G.
    BLOOD, 2024, 144 (01) : 61 - 73
  • [23] Utility of ursodiol prophylaxis against sinusoidal obstruction syndrome (SOS)/ veno-occlusive disease (VOD) in acute leukemia patients receiving gemtuzumab-ozogamicin (GO) or inotuzumab-ozogamicin (InO)
    Mosallam, Grace
    Winer, Eric S.
    Keating, Julia H.
    Flamand, Yael
    Solodokin, Loriel J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [24] Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia
    Dahl, Jenny
    Marx, Kayleigh
    Jabbour, Elias
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (04) : 329 - 334
  • [25] Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia
    Morley, N. J.
    Marks, D. I.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 159 - 164
  • [26] Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia Reply
    Kantarjian, Hagop M.
    Vandendries, Erik
    Advani, Anjali S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2100 - 2101
  • [27] Olverembatinib combined with inotuzumab ozogamicin in relapsed refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report
    Liu, Tong
    Wang, Chang
    Fu, Yu
    Yang, Yan-ping
    Tan, Ye-hui
    MEDICINE, 2024, 103 (29)
  • [28] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
    Tvito, Ariella
    Rowe, Jacob M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (12) : 1557 - 1564
  • [29] Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
    Ricart, Alejandro D.
    CLINICAL CANCER RESEARCH, 2011, 17 (20) : 6417 - 6427
  • [30] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
    Savoy, J. Michael
    Welch, Mary Alma
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (12) : 347 - 356
12345